Recombinant fucosyltransferase from Helicobacter pylori plays a key role in conveying IgG antibodies to the glycocalyx on the surfaces of live cells when the antibody is conjugated to the enzyme's natural donor substrate GDP-fucose.
Molecular Weight
39 kDa
Source
Helicobacter pylori
Form
Solution
Purity
>95%, determined by SDS-PAGE.
Applications
Recombinant fucosyltransferase from Helicobacter pylori is useful for the investigation of peptic ulcers, gastritis, and stomach cancer.
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.